NCT05036161View on ClinicalTrials.gov

ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

December 1, 2023

Conditions
Predictive Value of Tests
Interventions
OTHER

Nasal high flow

Newborns with respiratory distress treated with NHF.

OTHER

Continuous Positive Airway Pressure

Newborns with respiratory distress treated with CPAP.

Trial Locations (3)

Unknown

RECRUITING

Erebouni Medical Centre, NICU, Yerevan

NOT_YET_RECRUITING

Republican Institute of Reproductive Health, NICU, Yerevan

NOT_YET_RECRUITING

Research Center of Maternal and Child Health Protection NICU, Yerevan

Sponsors
All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Erebouni Medical Center

OTHER